Characteristics of Pediatric Patients With Relapsing Remitting Multiple Sclerosis Taking Disease Modifying Agents

Value in Health - United Kingdom
doi 10.1016/j.jval.2015.09.347
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Descriptive Evalaution of Characteristics of Patients Diagnosed With Relapsing Remitting Multiple Sclerosis and Taking Disease Modifying Agents

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2015English

Disease-Modifying Therapies in Relapsing–remitting Multiple Sclerosis

Neuropsychiatric Disease and Treatment
PsychiatryMental HealthBiological Psychiatry
2010English

Disease-Modifying Drugs for Relapsing-Remitting Multiple Sclerosis and Future Directions for Multiple Sclerosis Therapeutics

Archives of Neurology
1999English

Cognitive Profile of Patients With Relapsing Remitting Multiple Sclerosis

Arquivos de Neuro-Psiquiatria
Biological PsychiatryNeurology
1999English

Comparing the Quality of Life Among Patients With Relapsing Remitting Multiple Sclerosis in Iraq Using Different Disease Modifying Therapies

Iraqi Journal of Pharmaceutical Sciences
ToxicologyAnalytical ChemistryPharmaceuticsPharmacology
2018English

Progressive Gray Matter Damage in Patients With Relapsing-Remitting Multiple Sclerosis

Archives of Neurology
2005English

Cerebrovascular Reactivity and Disease Activity in Relapsing-Remitting Multiple Sclerosis

Advances in Clinical and Experimental Medicine
BiochemistryMedicineGeneticsMolecular Biology
2020English

Intestinal Permeability in Relapsing-Remitting Multiple Sclerosis

Neurotherapeutics
NeurologyPharmacology
2017English

Hypogammaglobulinemia in Multiple Sclerosis Patients Receiving Disease-Modifying Immunomodulatory Agents

Journal of Allergy and Clinical Immunology
AllergyImmunology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy